BGI Genomics Co., Ltd. (SHE:300676)

BGI Genomics Statistics

Total Valuation

BGI Genomics has a market cap or net worth of CNY 18.71 billion. The enterprise value is 15.62 billion.

Market Cap	18.71B
Enterprise Value	15.62B

Important Dates

The next estimated earnings date is Friday, October 31, 2025.

Earnings Date	Oct 31, 2025
Ex-Dividend Date	Jul 4, 2024

Share Statistics

BGI Genomics has 383.85 million shares outstanding. The number of shares has decreased by -1.73% in one year.

Current Share Class	383.85M
Shares Outstanding	383.85M
Shares Change (YoY)	-1.73%
Shares Change (QoQ)	+1.64%
Owned by Insiders (%)	1.10%
Owned by Institutions (%)	10.75%
Float	217.16M

Valuation Ratios

PE Ratio	n/a
Forward PE	744.63
PS Ratio	5.16
PB Ratio	1.99
P/TBV Ratio	2.11
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-17.07
EV / Sales	4.31
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-18.98

Financial Position

The company has a current ratio of 2.81, with a Debt / Equity ratio of 0.09.

Current Ratio	2.81
Quick Ratio	2.50
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	-1.04
Interest Coverage	-27.96

Financial Efficiency

Return on equity (ROE) is -9.48% and return on invested capital (ROIC) is -5.02%.

Return on Equity (ROE)	-9.48%
Return on Assets (ROA)	-4.05%
Return on Invested Capital (ROIC)	-5.02%
Return on Capital Employed (ROCE)	-8.32%
Revenue Per Employee	979,725
Profits Per Employee	-247,194
Employee Count	3,702
Asset Turnover	0.28
Inventory Turnover	3.92

Taxes

In the past 12 months, BGI Genomics has paid 3.35 million in taxes.

Income Tax	3.35M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +34.74% in the last 52 weeks. The beta is 0.74, so BGI Genomics's price volatility has been lower than the market average.

Beta (5Y)	0.74
52-Week Price Change	+34.74%
50-Day Moving Average	52.16
200-Day Moving Average	50.91
Relative Strength Index (RSI)	38.84
Average Volume (20 Days)	10,013,496

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BGI Genomics had revenue of CNY 3.63 billion and -915.11 million in losses. Loss per share was -2.23.

Revenue	3.63B
Gross Profit	1.34B
Operating Income	-838.16M
Pretax Income	-924.76M
Net Income	-915.11M
EBITDA	-424.06M
EBIT	-838.16M
Loss Per Share	-2.23

Balance Sheet

The company has 4.08 billion in cash and 853.84 million in debt, giving a net cash position of 3.23 billion or 8.41 per share.

Cash & Cash Equivalents	4.08B
Total Debt	853.84M
Net Cash	3.23B
Net Cash Per Share	8.41
Equity (Book Value)	9.39B
Book Value Per Share	22.08
Working Capital	4.37B

Cash Flow

In the last 12 months, operating cash flow was -237.64 million and capital expenditures -585.27 million, giving a free cash flow of -822.91 million.

Operating Cash Flow	-237.64M
Capital Expenditures	-585.27M
Free Cash Flow	-822.91M
FCF Per Share	-2.14

Margins

Gross margin is 37.03%, with operating and profit margins of -23.11% and -25.23%.

Gross Margin	37.03%
Operating Margin	-23.11%
Pretax Margin	-25.50%
Profit Margin	-25.23%
EBITDA Margin	-11.69%
EBIT Margin	-23.11%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.21%.

Dividend Per Share	0.10
Dividend Yield	0.21%
Dividend Growth (YoY)	-90.00%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	1.73%
Shareholder Yield	1.93%
Earnings Yield	-4.89%
FCF Yield	-4.40%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BGI Genomics has an Altman Z-Score of 4.32 and a Piotroski F-Score of 2.

Altman Z-Score	4.32
Piotroski F-Score	2